Acri Phase One is a clinical research site located in Anaheim, California, United States 92801.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
Acri Phase One has participated in 1 clinical trials.
Therapeutic areas: Hepatitis C.
Sponsors: Bristol-Myers Squibb.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Acri Phase One has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Acri Phase One has 1 clinical trials on record. Their work covers Hepatitis C.
Acri Phase One has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.